Tenet Healthcare (THC)
(Delayed Data from NYSE)
$165.84 USD
+1.17 (0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $165.85 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$165.84 USD
+1.17 (0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $165.85 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
Zacks News
Tenet Healthcare (THC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 22.41% and 4.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Tenet (THC) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 23.56% and 1.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.
4 Stocks in Focus as Hospital Industry Witnesses Improvement
by Kaibalya Pravo Dey
Easing staffing challenges and technological adoption are aiding the margins of the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Acadia (ACHC) and Tenet Healthcare (THC) are poised to gain from improving volumes.
ACHC or THC: Which Hospital Stock is Better-Positioned?
by Zacks Equity Research
Acadia Healthcare (ACHC) and Tenet Healthcare (THC) are poised to grow in the promising hospital space. We try to find out which stock fares better via comparative evaluation.
Tenet Healthcare (THC) Jumps 14.9% YTD: More Growth Ahead?
by Zacks Equity Research
Tenet Healthcare's (THC) focus on boosting USPI's network is positioning the company for expedited growth.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Acadia Healthcare (ACHC) Gains From Expansion Initiatives
by Zacks Equity Research
Acadia Healthcare (ACHC) gains from solid top line stemming from continuous bed additions and higher patient volumes. A credible financial position drives its expansion endeavors.
Universal Health (UHS) Q4 Earnings Beat on Solid Segments
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results indicate growing revenues in its segments resulting from higher patient volumes. Management expects adjusted EPS within $9.50-$10.50 for 2023.
Community Health (CYH) Q4 Earnings Beat on Strong Admissions
by Zacks Equity Research
Community Health's (CYH) fourth-quarter results indicate growing patient volumes. However, management estimates net loss per share to lie between 65 cents and 5 cents in 2023.
Tenet (THC) Q4 Earnings Beat on Ambulatory Care Strength
by Zacks Equity Research
Tenet Healthcare's (THC) bottom line deteriorates due to higher operating expenses, partially offset by an improving Ambulatory Care segment.
Tenet Healthcare (THC) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 54.33% and 1.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -3.13% and 0.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.
Investors Should Watch These 4 Hospital Stocks Despite Headwinds
by Kaibalya Pravo Dey
Rising costs amid inflationary pressures are trimming margins for the Zacks Medical-Hospital industry players. Yet, HCA Healthcare (HCA), Universal Health (UHS), Acadia Healthcare (ACHC) and Tenet Healthcare (THC) are poised to win big with improving volumes.
Tenet Healthcare (THC) Q3 Earnings Beat, Down Y/Y, Shares Drop
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results reflect a dismal performance of the Hospital Operations and Other segment as well as continued pressure on patient volumes from the pandemic.
4 Stocks Navigating Through Hospital Industry Headwinds (Revised)
by Kaibalya Pravo Dey
Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.
HCA Healthcare (HCA) Q3 Earnings Beat, Revenues Decline Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results reflect a slight dip in expenses but lower revenues resulting from the havoc wreaked by Hurricane Ian on its Florida facilities.
Zacks Industry Outlook Highlights HCA Healthcare, Acadia Healthcare, Universal Health Services and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Acadia Healthcare, Universal Health Services and Tenet Healthcare have been highlighted in this Industry Outlook article.
Tenet Healthcare (THC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 12.50% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Stocks Navigating Through Hospital Industry Headwinds
by Kaibalya Pravo Dey
Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.
Why Tenet Healthcare (THC) Might Surprise This Earnings Season
by Zacks Equity Research
Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.